{"meshTagsMajor":["Mutation"],"meshTags":["Adenocarcinoma","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","DNA, Neoplasm","Female","Follow-Up Studies","Humans","Immunohistochemistry","In Situ Hybridization","Lung Neoplasms","Maytansine","Middle Aged","Mutation","Neoplasm Staging","Nucleic Acid Amplification Techniques","Positron-Emission Tomography","Receptor, ErbB-2"],"meshMinor":["Adenocarcinoma","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","DNA, Neoplasm","Female","Follow-Up Studies","Humans","Immunohistochemistry","In Situ Hybridization","Lung Neoplasms","Maytansine","Middle Aged","Neoplasm Staging","Nucleic Acid Amplification Techniques","Positron-Emission Tomography","Receptor, ErbB-2"],"genes":["HER2"],"organisms":["9606"],"publicationTypes":["Case Reports","Journal Article"],"title":"Rapid response to trastuzumab emtansine in a patient with HER2-driven lung cancer.","pubmedId":"25789838"}